Allevi

Philadelphia, United States Founded: 2014 • Age: 12 yrs Acquired By 3D Systems
Industrial-grade 3D bioprinters and bioprinting materials are manufactured.

About Allevi

Allevi is a Healthcare company based in Philadelphia (United States) founded in 2014 by Ricky Solorzano, and was acquired by 3D Systems in May 2021. Industrial-grade 3D bioprinters and bioprinting materials are manufactured. It operates on a Direct-to-Consumer (D2C) model in Healthcare and Technology sectors. Allevi has raised $3.58 million across 5 funding rounds from investors including 3D Systems, Penn Medicine and 500 Global. Its chief executive, as recorded, is Ricky Solorzano. Allevi offers products and services including Allevi 3D Bioprinters and Bioinks. Its focus areas include Biotechnology and Bioprinting. Its legal entity is Allevi, Inc. Its competitors include CELLINK, Precise Bio and BICO; 1 of its 3 listed competitors has raised funding.

Company details

Allevi, part of 3D Systems since 2021, is focused on delivering advanced 3D bioprinting technologies and materials. Solutions are developed for tissue engineering, organ-on-a-chip, and disease modeling. Their bioprinters and bioinks are utilized by researchers globally to address challenges in regenerative medicine, drug discovery, and clinical research. Applications are supported across sectors like cancer biology, vaccine development, and stem cell therapeutics.

  • Headquarters Philadelphia, United States
  • Founders Ricky Solorzano
  • Stage Acquired
  • Sectors
    Healthcare
    Technology
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website allevi3d.com
  • Social LinkedIn X Facebook YouTube
  • Acquired by 3D Systems (May 2021)
  • Legal Name Allevi, Inc.
Key Metrics
  • Total Equity Funding
    $3.58M (USD)

    in 5 rounds

  • Latest Funding Round
    $1M (USD), Seed

    Oct 2019

  • Investors
    3D Systems

    & 5 more

  • Acquired by
    3D Systems

    (May 2021)

Products & Services of Allevi

Allevi offers a comprehensive portfolio of products and services, including Allevi 3D Bioprinters and Bioinks.

Allevi 3D Bioprinters
Bioprinting Technology

Advanced bioprinters are offered for 3D tissue engineering.

Bioinks
Bioprinting Materials

Various bioinks are provided for tissue-specific bioprinting applications.

Apps and channels of Allevi

its YouTube channel Allevi Inc has 664 subscribers and 30 videos.

Allevi Inc
YouTube 664 subscribers 30 videos Science & Technology
Open channel

Videos from Allevi

The most watched videos on Allevi's YouTube channel, Allevi Inc (664 subscribers). Click a video to play it here.

What is 3D Bioprinting? | Bioprinting Explained | Allevi
18.4K views
Introducing Allevi 3 - Versatile & Powerful Bioprinting
5.8K views
Gelatin Methacrylate Instructions
4.7K views
Hyperelastic Bone by Dimension Inx | Allevi Inc
4.5K views

More on Allevi Inc.

Funding Insights of Allevi

Allevi has successfully raised a total of $3.58M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $1 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.58M
  • Total Rounds 5
  • Last Round Seed β€” $1M
  • First Round $50,000

    (Oct 2014)

  • Investors Count 5

All 5 funding rounds of Allevi with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2019$1MSeed––
–
Nov 2017$30,000Seed––
–
Sep 2015$1.25MSeed––
Aug 2015$1.25MSeed–500 Global, Ben Franklin Technology Partners
Oct 2014$50,000Seed––
Valuation history

6 investors in total: 6 institutional.

Investors in Allevi

Allevi has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include 3D Systems, Penn Medicine and 500 Global.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital and acceleration are provided to tech startups.
500.coHo Chi Minh City, Vietnam
Startup accelerator
dreamit.comNew York, United States
Technology ecosystem growth is supported in Southeastern Pennsylvania.
sep.benfranklin.orgPhiladelphia, United States
Health insurance services are provided by Independence Blue Cross.
ibx.comPhiladelphia, United States
Health System
1993pennmedicine.orgUnited States
Provider of solid imaging solutions
19863dsystems.comRock Hill, United States
Premium access

Investor details for Allevi

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Allevi

292 people are tracked at Allevi (75 in leadership, 217 in team).

NameRoleGroup
Ricky Solorzano
Co-Founder & CEOLeadership
Jeffrey A. Graves
President & CEOLeadership
Wayne Pensky
Interim Chief Financial OfficerLeadership
Gene Fischer
Director Of Global OperationsLeadership
Kevin Tempels
Finance DirectorLeadership
Robert Milot
Finance Director - Corporate Fp&aLeadership
Chaim Huijsman
Vice President Global Order Management, Logistics & DistributionLeadership
Chen Izik
Director Of Finance Global Customer ServicesLeadership
Jason Crowe
Head Of Global Talent AcquisitionLeadership
Kirsten Rozycki
Vice President, Employment, Labor & Corporate CounselLeadership
Joshua McCormick
Director, Quality AssuranceLeadership
Dennis Jung
General Manager At 3d Systems Korea (대표이사)Leadership
Craig White
Director Of Sales - Western RegionLeadership
Lk Zhang
Director Of Channel SalesLeadership
Jérémy A.
Finance Director - Global Cost Of Sales & Supply ChainLeadership
Johannes Marius Euler
Director, Global Material SalesLeadership
Scott Polk
Vice President Of QualityLeadership
Shannon Grant Abbott
Director, Global Indirect ProcurementLeadership
Michelle Baek
Director Of Asia SalesLeadership
Michael Allen
Director Global Technical SupportLeadership

272 more people are available in the full profile.

Premium access

Complete people profiles for Allevi

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Allevi

4 dated milestones of Allevi across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Allevi is founded.
  2. Funding First funding round of $50K.
  3. Funding Latest funding round, Seed, of $1.0M.
  4. Exit Acquired by 3D Systems.

Competitors of Allevi

Allevi has 3 listed competitors in our database, 1 of them funded. They include CELLINK, Precise Bio and BICO.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cellink.com2016Boston, United States65
3D bioprinters and bioinks are developed for research applications.
precise-bio.com2015Winston-salem, United States$12M6
Developer of integrated 3D printing and tissue-engineering platform
bico.com2016Boston, United States955
Technologies, products, and services for life sciences research are provided.
Premium access

Detailed competitors of Allevi

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Allevi

The website of Allevi (allevi3d.com) receives about 7K visits a month.

  • Monthly visits
    7K

    ▲ 32.7% vs previous month

Similar websites

Websites whose visitors overlap most with Allevi. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
exalpha.com
100%
#5,883,755View details
cellink.com
83%
56.1K#623,928View details

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Allevi (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Allevi

Premium access

Complete news archive for Allevi

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Allevi

Allevi was founded in 2014.

Allevi is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.

Ricky Solorzano is the CEO of Allevi, as recorded in our data. They have also founded this company.

Allevi is a funded company, having raised a total of $3.58M across 5 funding rounds to date. The company's 1st funding round was a Seed of $50K, raised on Oct 2014.

Allevi, part of 3D Systems since 2021, is focused on delivering advanced 3D bioprinting technologies and materials. Solutions are developed for tissue engineering, organ-on-a-chip, and disease modeling. Their bioprinters and bioinks are utilized by researchers globally to address challenges in regenerative medicine, drug discovery, and clinical research. Applications are supported across sectors like cancer biology, vaccine development, and stem cell therapeutics.

Allevi's top competitors include CELLINK, BICO and Precise Bio.

Allevi offers Allevi 3D Bioprinters and Bioinks.

Allevi has 6 investors. Key investors include 3D Systems, Penn Medicine, 500 Global, Dreamit, and Ben Franklin Technology Partners.

Allevi operates through Allevi, Inc..

Yes. Allevi was acquired by 3D Systems in May 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available